Abstract
Abstract
Background
Selective androgen receptor modulators (SARMs) are becoming increasingly common amongst athletes and the general population, but their side effect profile in human subjects at recreational doses is understudied.
Case presentation
A 27-year-old asymptomatic male weightlifter presented for an annual physical exam and was coincidentally found to have an abnormal lipid panel, which the patient believed to be due to recreational SARMs (LGD-4033 and S-23) usage. Further work-up revealed elevated liver enzymes suggestive of hepatocellular injury and suppression of the pituitary–gonadal axis. Lipids, hepatic function, and hormones returned to baseline after cessation of SARMs.
Conclusions
This is the first case report on how SARMs may impact LDL, cause hepatocellular rather than cholestatic liver injury, and alter health markers despite complete lack of symptoms. It is also the first case report on the potential negative effects of the SARM S-23.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Akhtar N, Locke D, Stine J (2021) S2851 harm by SARM: a case of drug-induced liver injury in an amateur bodybuilder. Off J Am Coll Gastroenterol ACG 116:S1184
2. Barbara M, Dhingra S, Mindikoglu AL (2020) Ligandrol (LGD-4033)-induced liver injury. ACG Case Rep J 7(6):e00370
3. Barbara M, Dhingra S, Mindikoglu AL (2020) Drug-induced liver injury associated with alpha bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033). ACG Case Rep J 7(6):e00409
4. Basaria S, Collins L, Dillon EL et al (2013) The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol Ser Biomed Sci Med Sci 68(1):87–95
5. Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM (2021) Drug-induced liver injury from enobosarm (ostarine), a selective androgen receptor modulator. ACG Case Rep J 8(1):e00518
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献